A 42-year-old soldier from Fort Benning sits in my office and tells me he is fine. His total testosterone is 410 ng/dL — squarely inside the lab's reference range, so his primary care provider has told him there is nothing to address. But his sleep has been thin for the last two years. His morning erections, once reliable, are now intermittent. His recovery from the same workouts he has done for fifteen years is taking days instead of hours. His mood has flattened in a way his wife noticed before he did. He is irritable in a way that does not fit his personality. He wants to know what is going on.
What is going on is the andropause window — the multi-year period, usually starting somewhere in the late thirties to mid-forties, when male hormone production begins its gradual decline and the symptoms appear well before the lab values cross a threshold that triggers a "low" flag. The patient described above is exactly the patient I see most often in this category. The conventional system tells him he is normal. His body tells him he is not. Both are technically correct, and the resolution is in understanding what "normal" actually measures.
What the andropause window actually is
Male hormone decline is not a sudden event the way menopause is in women. Testosterone production begins to drop by roughly one to two percent per year starting in the early thirties, and the trajectory accelerates in some men in mid-life. By the late forties most men have meaningfully lower total testosterone than they had at 25, even when they remain inside the population reference range.
The reference range itself is part of the problem. The lower bound — usually around 264 to 300 ng/dL depending on the assay — was derived from a population that included substantial numbers of older men with symptomatic deficiency. Being inside the range tells you that you are not at the low extreme of a population that already includes men who are symptomatic. It does not tell you that your hormonal state is supporting your physiology.
The window — the years when symptoms are appearing but labs have not crossed the threshold for a primary care diagnosis — is usually where I meet patients. They have noticed the changes themselves or their partners have noticed first. They are functional, often high-functioning, but they know something has shifted. The clinical question is not whether they are deficient by the lab definition; it is whether their current hormonal state is producing symptoms that are addressable.
The mechanism: why symptoms appear before the threshold is crossed
Total testosterone is a misleading single number. What matters at the tissue level is free testosterone — the fraction not bound to sex hormone binding globulin (SHBG) or albumin — because that is the fraction available to act on receptors. SHBG rises with age, with insulin resistance, with thyroid issues, and with certain medications. As SHBG rises, free testosterone falls even when total testosterone looks unchanged.
A man with a total testosterone of 500 and an SHBG of 25 has substantially more bioavailable testosterone than the same man at total 500 with an SHBG of 65. The first man feels fine. The second man does not. Both have "normal" total testosterone. This is the most common reason I see symptomatic men get told there is nothing wrong on a routine workup.
Receptor sensitivity matters as well. Androgen receptor density and sensitivity vary across individuals and decline somewhat with age and chronic inflammation. Two patients with identical lab values can have different symptom pictures because of receptor differences alone.
Estradiol — yes, men make estradiol, and they need it — also matters. Testosterone aromatizes to estradiol, which is critical for bone health, libido, mood, and cardiovascular function in men. The balance is what matters, not any single number.
The other piece I evaluate in every workup is the HPG axis itself — LH and FSH. Whether the testicles are still capable of producing testosterone in response to brain signals (secondary hypogonadism) versus whether the testicles themselves are no longer responding (primary hypogonadism) changes what the right intervention is.
The symptoms I take seriously, even with "normal" labs
Sleep changes are usually the earliest. Men in the andropause window often describe falling asleep without difficulty but waking at 3 or 4 a.m. and not returning to deep sleep. Testosterone is released primarily during slow-wave and REM sleep — fragmented sleep architecture both reflects and worsens the hormonal picture.
Recovery from exercise is the second pattern. Men who have trained the same way for years notice that the same workout that used to leave them sore for a day now leaves them sore for three. Strength stalls or regresses despite consistent training. Visceral fat accumulates around the midsection in a way that diet and exercise do not reverse the way they used to.
Morning erections — the nocturnal tumescence pattern — are a sensitive marker of androgen status. Their progressive decline over months or years is meaningful clinical data, and it is something I ask about specifically because most patients will not volunteer it. Libido changes track similarly.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
Mood changes are real but easy to misattribute. Irritability, lower frustration tolerance, a flattening of motivation and drive — these can be hormonal, situational, or both. The pattern that suggests hormonal contribution is when these changes are out of character, have developed gradually over a year or more, and are accompanied by the physical symptoms above.
Cognitive symptoms — word-finding difficulty, slower processing, the sense of mental sharpness having dulled — show up later in many patients but are equally real. They tend to recover with hormonal optimization in patients whose decline was the driver.
How I evaluate a patient at the first visit
The first hormone consultation is structured. I want a complete history — medical, surgical, medications, supplements, family. I want a detailed symptom inventory across the domains above with specific timing of onset. I want lifestyle baseline — sleep, training, nutrition, alcohol, stress. I want to know what prior providers have told you and what labs have already been done.
The lab panel I order is more comprehensive than the standard primary care workup. Total testosterone and free testosterone (calculated from total, SHBG, and albumin), SHBG, estradiol (sensitive assay, not the standard immunoassay), DHEA-S, LH, FSH, prolactin, and PSA as a baseline. Full thyroid: TSH, free T3, free T4, reverse T3, thyroid antibodies. Metabolic: fasting insulin, HbA1c, fasting glucose, comprehensive metabolic panel, lipid panel. Inflammatory: hs-CRP, ferritin. Vitamin D. The hormone health assessment is a useful starting frame for the visit, but the labs are what build the actual picture.
The second visit is the lab review. We sit with the data together, and I walk you through what each marker means in the context of your symptoms. By that visit, the conversation about treatment is grounded in actual physiology, not in pattern matching.
Who is a candidate — and who is not
A good candidate for men's testosterone replacement typically has a symptom cluster that has persisted at least three months, lab values that confirm a hormonal mechanism (not always a "low" total testosterone — sometimes elevated SHBG with crashed free testosterone, sometimes secondary hypogonadism with intact response to stimulation, sometimes a thyroid issue masquerading as a testosterone issue), realistic expectations about timeline, willingness to do follow-up labs at three months, and absence of contraindications.
The contraindications I take seriously: untreated prostate cancer, untreated severe sleep apnea (testosterone can worsen apnea, so the apnea gets treated first), elevated hematocrit (which testosterone can push higher), uncontrolled heart failure, active fertility goals (in which case the protocol changes — exogenous testosterone suppresses spermatogenesis, and patients trying to conceive need a different approach involving HCG, clomiphene, or enclomiphene rather than direct testosterone replacement).
Patients I do not start on TRT include those whose symptoms are better explained by another untreated condition. The most common ones I see: untreated sleep apnea, undiagnosed depression that needs its own treatment, alcohol use that is meaningfully driving the symptom picture, untreated thyroid disease that is producing testosterone-like symptoms, and overtraining with chronic energy deficit. Treating those patients with testosterone before addressing the actual driver does not work, and I will tell you that directly rather than write a prescription that is unlikely to help.
How treatment proceeds when it is the right call
Treatment is conservative and titrated. I do not front-load dose. The patients who do best are the ones whose levels are brought into a stable optimal range over weeks to months, with follow-up labs at six to eight weeks to confirm where the dose has landed and adjust from there.
Delivery method depends on the patient. Injections — testosterone cypionate weekly or twice-weekly — produce the most predictable levels and are the most cost-effective. Transdermal preparations work well for some patients and are more flexible. Biote pellet therapy suits patients who prefer not to deal with injections or daily applications and want a longer interval between visits, with the trade-off that dose adjustment is less granular. The right choice depends on the patient's preferences and on the specific clinical picture.
Adjuncts matter. Many men need an aromatase inhibitor at low dose to manage estradiol if it rises too high on therapy, though the goal is balance, not suppression — over-suppressing estradiol produces its own set of problems. HCG may be added to preserve testicular function and fertility. Thyroid optimization happens in parallel when the labs warrant it. The picture is treated as a system, not as a single number.
The local context and the next step
In Columbus, Warner Robins, and the broader middle Georgia patient population, I see a meaningful number of patients connected to Fort Benning — active duty, retired, contractors, and family. The combination of physical demands, deployment history, sleep disruption, and chronic stress in this population produces hormonal pictures that often deserve evaluation earlier than the standard primary care timeline would trigger. If you are in this group and the symptoms above are familiar, the workup is worth doing.
The next step is the comprehensive lab work and a consultation to interpret it. Pull whatever prior labs you have — even old ones, from years back — and bring them with you. Trends over time are often more useful than any single snapshot. You can book a consultation at either the Columbus location or the Warner Robins location. The first visit will tell us whether the andropause window is what you are in, what the underlying mechanism is, and whether intervention is the right call for your specific physiology.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.